| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1A ATRX CCT3 MYO6 DDX60 RNF213 RECQL ABCF2 YTHDC2 INO80 ATAD2 ATP13A2 ABCA9 ZRANB3 DNAH14 CCT5 KCNJ11 SMARCA2 NAV2 SMARCA4 DDX60L ATP2A2 DNAH8 ATP2B1 ATP2B4 | 3.02e-10 | 614 | 180 | 25 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP6V1A ATRX CCT3 DDX60 RNF213 RECQL ABCF2 YTHDC2 INO80 ATAD2 ATP13A2 ABCA9 CCT5 NAV2 SMARCA4 DDX60L ATP2A2 DNAH8 ATP2B1 ATP2B4 | 3.38e-09 | 441 | 180 | 20 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP6V1A ATRX CCT3 DDX60 RNF213 RECQL ABCF2 YTHDC2 INO80 ATAD2 ATP13A2 ABCA9 CCT5 NAV2 SMARCA4 DDX60L GNG3 ATP2A2 DNAH8 ATP2B1 ATP2B4 | 7.10e-06 | 775 | 180 | 21 | GO:0017111 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNG1 TPCN2 GRIN2C PKDREJ CATSPER4 ATP2A2 ATP2B1 ATP2B4 TRPV5 | 9.47e-06 | 151 | 180 | 9 | GO:0015085 |
| GeneOntologyMolecularFunction | helicase activity | 1.36e-05 | 158 | 180 | 9 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.94e-05 | 37 | 180 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.00e-05 | 62 | 180 | 6 | GO:0019829 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP6V1A ATRX CCT3 DDX60 RNF213 RECQL ABCF2 YTHDC2 INO80 ATAD2 ATP13A2 ABCA9 CCT5 NAV2 SMARCA4 DDX60L GNG3 ATP2A2 DNAH8 ATP2B1 ATP2B4 | 2.33e-05 | 839 | 180 | 21 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP6V1A ATRX CCT3 DDX60 RNF213 RECQL ABCF2 YTHDC2 INO80 ATAD2 ATP13A2 ABCA9 CCT5 NAV2 SMARCA4 DDX60L GNG3 ATP2A2 DNAH8 ATP2B1 ATP2B4 | 2.37e-05 | 840 | 180 | 21 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP6V1A ATRX CCT3 DDX60 RNF213 RECQL ABCF2 YTHDC2 INO80 ATAD2 ATP13A2 ABCA9 CCT5 NAV2 SMARCA4 DDX60L GNG3 ATP2A2 DNAH8 ATP2B1 ATP2B4 | 2.37e-05 | 840 | 180 | 21 | GO:0016818 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | RASGRF1 DOCK11 DOCK8 SH2D3C RCC1 ELMO1 RASGRP1 RIN2 DOCK7 DOCK6 | 4.86e-05 | 231 | 180 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 5.92e-05 | 109 | 180 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | thiosulfate transmembrane transporter activity | 8.08e-05 | 2 | 180 | 2 | GO:0015117 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.13e-04 | 11 | 180 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.55e-04 | 127 | 180 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | malate transmembrane transporter activity | 2.41e-04 | 3 | 180 | 2 | GO:0015140 | |
| GeneOntologyMolecularFunction | oxaloacetate transmembrane transporter activity | 2.41e-04 | 3 | 180 | 2 | GO:0015131 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 3.00e-04 | 36 | 180 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 3.00e-04 | 36 | 180 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRG3 ATP6V1A ANO9 CACNG1 TPCN2 SLC38A4 GRIN2C PKDREJ SLC15A1 CATSPER4 KCNJ11 SLC25A10 SLC25A11 ATP2A2 ATP2B1 ATP2B4 TRPV5 | 5.18e-04 | 758 | 180 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | calcium channel activity | 1.12e-03 | 129 | 180 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.15e-03 | 51 | 180 | 4 | GO:0043394 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.18e-03 | 178 | 180 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | succinate transmembrane transporter activity | 1.18e-03 | 6 | 180 | 2 | GO:0015141 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP6V1A SLC38A4 SLC35E1 ATP13A2 ABCA9 SLC15A1 KCNJ11 SLC25A10 SLC25A11 ATP2A2 ATP2B1 ATP2B4 | 1.34e-03 | 477 | 180 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.76e-03 | 303 | 180 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | MYT1L SIN3B PHF24 TRRAP PIAS1 RBCK1 CNOT6 KMT2D NFKB1 SMARCA2 SMARCA4 SMARCE1 TAF5L | 1.80e-03 | 562 | 180 | 13 | GO:0003712 |
| GeneOntologyMolecularFunction | molecular sequestering activity | 1.98e-03 | 59 | 180 | 4 | GO:0140313 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.00e-03 | 28 | 180 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 2.18e-03 | 8 | 180 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | AARS1 ATRX DDX60 RECQL YTHDC2 INO80 PTBP1 ZRANB3 CNOT6 CNOT6L SMARCA2 NAV2 SMARCA4 DDX60L | 2.19e-03 | 645 | 180 | 14 | GO:0140640 |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 2.22e-03 | 29 | 180 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRG3 ATP6V1A ANO9 CACNG1 TPCN2 SLC38A4 GRIN2C PKDREJ ATP13A2 SLC15A1 CATSPER4 KCNJ11 ATP2A2 ATP2B1 ATP2B4 TRPV5 | 2.25e-03 | 793 | 180 | 16 | GO:0015075 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.66e-03 | 262 | 180 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP6V1A CACNG1 TPCN2 SLC38A4 GRIN2C PKDREJ ATP13A2 SLC15A1 CATSPER4 KCNJ11 ATP2A2 ATP2B1 ATP2B4 TRPV5 | 2.84e-03 | 664 | 180 | 14 | GO:0008324 |
| GeneOntologyCellularComponent | bBAF complex | 7.33e-05 | 10 | 181 | 3 | GO:0140092 | |
| GeneOntologyCellularComponent | ribbon synapse | 1.62e-04 | 32 | 181 | 4 | GO:0097470 | |
| GeneOntologyCellularComponent | npBAF complex | 2.17e-04 | 14 | 181 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 2.86e-04 | 193 | 181 | 8 | GO:0000779 | |
| GeneOntologyCellularComponent | nBAF complex | 3.29e-04 | 16 | 181 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.73e-04 | 253 | 181 | 9 | GO:0030427 | |
| GeneOntologyCellularComponent | leading edge membrane | 5.03e-04 | 210 | 181 | 8 | GO:0031256 | |
| HumanPheno | Abnormal nasal tip morphology | MYT1L TLK2 ATP6V1A ATRX PUF60 TRRAP KMT2D PTPRF CCDC47 ASXL3 DOCK7 SMARCA2 SMARCA4 SMG9 SMARCE1 DOCK6 | 7.38e-06 | 386 | 61 | 16 | HP:0000436 |
| HumanPheno | Long eyelashes | PUF60 KMT2D CCDC47 ASXL3 AP3B2 DOCK7 SMARCA2 SMARCA4 SMARCE1 | 1.84e-05 | 129 | 61 | 9 | HP:0000527 |
| Domain | DUF3398 | 1.21e-07 | 6 | 179 | 4 | PF11878 | |
| Domain | DOCK_C/D_N | 1.21e-07 | 6 | 179 | 4 | IPR021816 | |
| Domain | Helicase_C | 8.93e-07 | 107 | 179 | 9 | PF00271 | |
| Domain | HELICc | 8.93e-07 | 107 | 179 | 9 | SM00490 | |
| Domain | Helicase_C | 9.66e-07 | 108 | 179 | 9 | IPR001650 | |
| Domain | HELICASE_CTER | 1.04e-06 | 109 | 179 | 9 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.04e-06 | 109 | 179 | 9 | PS51192 | |
| Domain | DEXDc | 1.04e-06 | 109 | 179 | 9 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.13e-06 | 110 | 179 | 9 | IPR014001 | |
| Domain | DHR-1_domain | 2.55e-06 | 11 | 179 | 4 | IPR027007 | |
| Domain | DHR_2 | 2.55e-06 | 11 | 179 | 4 | PS51651 | |
| Domain | DHR_1 | 2.55e-06 | 11 | 179 | 4 | PS51650 | |
| Domain | DHR-2 | 2.55e-06 | 11 | 179 | 4 | PF06920 | |
| Domain | DOCK | 2.55e-06 | 11 | 179 | 4 | IPR026791 | |
| Domain | DOCK_C | 2.55e-06 | 11 | 179 | 4 | IPR010703 | |
| Domain | DOCK-C2 | 2.55e-06 | 11 | 179 | 4 | PF14429 | |
| Domain | DHR-2 | 2.55e-06 | 11 | 179 | 4 | IPR027357 | |
| Domain | - | ADCY10 ATP6V1A ATRX DDX60 RNF213 RECQL ABCF2 YTHDC2 INO80 ATAD2 ABCA9 ZRANB3 DNAH14 NLRC4 EHD1 SMARCA2 NAV2 SMARCA4 SMG9 DDX60L DNAH8 CNP | 2.86e-06 | 746 | 179 | 22 | 3.40.50.300 |
| Domain | P-loop_NTPase | ADCY10 ATP6V1A ATRX MYO6 DDX60 RNF213 RECQL ABCF2 YTHDC2 INO80 ATAD2 ABCA9 ZRANB3 DNAH14 NLRC4 EHD1 SMARCA2 NAV2 SMARCA4 SMG9 DDX60L DNAH8 CNP | 6.69e-06 | 848 | 179 | 23 | IPR027417 |
| Domain | SNF2_N | 1.25e-05 | 32 | 179 | 5 | IPR000330 | |
| Domain | SNF2_N | 1.25e-05 | 32 | 179 | 5 | PF00176 | |
| Domain | IRO | 1.70e-05 | 6 | 179 | 3 | SM00548 | |
| Domain | Iroquois_homeo | 1.70e-05 | 6 | 179 | 3 | IPR003893 | |
| Domain | Cation_ATPase_N | 2.25e-05 | 18 | 179 | 4 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.83e-05 | 19 | 179 | 4 | IPR004014 | |
| Domain | VIT | 4.68e-05 | 8 | 179 | 3 | PF08487 | |
| Domain | VIT | 4.68e-05 | 8 | 179 | 3 | SM00609 | |
| Domain | Gln-Leu-Gln_QLQ | 9.13e-05 | 2 | 179 | 2 | IPR014978 | |
| Domain | SnAC | 9.13e-05 | 2 | 179 | 2 | PF14619 | |
| Domain | QLQ | 9.13e-05 | 2 | 179 | 2 | SM00951 | |
| Domain | QLQ | 9.13e-05 | 2 | 179 | 2 | PS51666 | |
| Domain | SnAC | 9.13e-05 | 2 | 179 | 2 | SM01314 | |
| Domain | SnAC | 9.13e-05 | 2 | 179 | 2 | IPR029295 | |
| Domain | ATP2B1/4 | 9.13e-05 | 2 | 179 | 2 | IPR030319 | |
| Domain | QLQ | 9.13e-05 | 2 | 179 | 2 | PF08880 | |
| Domain | VIT | 9.89e-05 | 10 | 179 | 3 | PS51468 | |
| Domain | VIT | 9.89e-05 | 10 | 179 | 3 | IPR013694 | |
| Domain | ATPase_P-typ_cyto_domN | 3.39e-04 | 35 | 179 | 4 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 3.78e-04 | 36 | 179 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 3.78e-04 | 36 | 179 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 3.78e-04 | 36 | 179 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.21e-04 | 37 | 179 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.21e-04 | 37 | 179 | 4 | PF00122 | |
| Domain | ARM-type_fold | HGH1 DOCK11 DOCK8 MROH2A UBR4 FRYL TRRAP ELMO1 THADA AP3B2 UNC79 | 4.42e-04 | 339 | 179 | 11 | IPR016024 |
| Domain | ATPase_P-typ_TM_dom | 4.42e-04 | 16 | 179 | 3 | IPR023298 | |
| Domain | - | 4.42e-04 | 16 | 179 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 5.33e-04 | 17 | 179 | 3 | IPR006068 | |
| Domain | Homeobox_KN | 5.33e-04 | 17 | 179 | 3 | PF05920 | |
| Domain | Cation_ATPase_C | 5.33e-04 | 17 | 179 | 3 | PF00689 | |
| Domain | Homeobox_KN_domain | 5.33e-04 | 17 | 179 | 3 | IPR008422 | |
| Domain | ATP_Ca_trans_C | 5.41e-04 | 4 | 179 | 2 | IPR022141 | |
| Domain | HSA | 5.41e-04 | 4 | 179 | 2 | SM00573 | |
| Domain | ATP_Ca_trans_C | 5.41e-04 | 4 | 179 | 2 | PF12424 | |
| Domain | HSA | 5.41e-04 | 4 | 179 | 2 | PS51204 | |
| Domain | P-type_ATPase_IIB | 5.41e-04 | 4 | 179 | 2 | IPR006408 | |
| Domain | HSA_dom | 5.41e-04 | 4 | 179 | 2 | IPR014012 | |
| Domain | HSA | 5.41e-04 | 4 | 179 | 2 | PF07529 | |
| Domain | Cation_ATPase_N | 6.35e-04 | 18 | 179 | 3 | PF00690 | |
| Domain | BRK | 1.34e-03 | 6 | 179 | 2 | SM00592 | |
| Domain | ITI_HC_C | 1.34e-03 | 6 | 179 | 2 | IPR010600 | |
| Domain | BRK_domain | 1.34e-03 | 6 | 179 | 2 | IPR006576 | |
| Domain | BRK | 1.34e-03 | 6 | 179 | 2 | PF07533 | |
| Domain | ITI_HC_C | 1.34e-03 | 6 | 179 | 2 | PF06668 | |
| Domain | RASGEF | 1.91e-03 | 26 | 179 | 3 | PS00720 | |
| Domain | VWA | 2.03e-03 | 56 | 179 | 4 | PF00092 | |
| Domain | RASGEF_CAT | 2.63e-03 | 29 | 179 | 3 | PS50009 | |
| Domain | AAA | 2.67e-03 | 144 | 179 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 2.67e-03 | 144 | 179 | 6 | IPR003593 | |
| Domain | RasGEF | 2.91e-03 | 30 | 179 | 3 | PF00617 | |
| Domain | - | 2.91e-03 | 30 | 179 | 3 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 2.91e-03 | 30 | 179 | 3 | IPR001895 | |
| Domain | RasGEF | 2.91e-03 | 30 | 179 | 3 | SM00147 | |
| Domain | Ras_GEF_dom | 2.91e-03 | 30 | 179 | 3 | IPR023578 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 3.46e-05 | 20 | 135 | 4 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 4.24e-05 | 21 | 135 | 4 | M27736 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.88e-05 | 176 | 135 | 9 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 6.60e-05 | 183 | 135 | 9 | M997 | |
| Pubmed | DAB2IP TLK2 FKBP15 SIN3B PDE4A MIA3 ITCH CCT3 DOCK11 SYNE1 SH3GL2 UBR4 EMSY CSNK1A1L PTPRD HOOK1 PTPRS CSNK1A1 DOCK7 LRP1 SMARCA4 AFDN UNC79 ATP2B4 CNP | 7.10e-11 | 963 | 185 | 25 | 28671696 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | ADCY10 CCT3 PUF60 DDX60 RNF213 YTHDC2 PTBP1 HOOK1 AP3B2 DOCK7 SMARCA4 SLC25A11 ATP2A2 | 1.08e-10 | 208 | 185 | 13 | 33230847 |
| Pubmed | SIN3B GGNBP2 ATRX SYNE1 SLC35E1 ABCF2 YTHDC2 INO80 ATAD2 TRRAP PIAS1 EMSY CNOT6 TMX2 CDK5RAP3 CNOT6L CCT5 CCDC47 CSNK1A1 MTFR1 SLC25A10 SMARCA2 AFDN SMARCE1 SLC25A11 TAF5L ATP2A2 CNP SDHA ZNF687 | 4.02e-10 | 1497 | 185 | 30 | 31527615 | |
| Pubmed | SETD1A AARS1 CCT3 PUF60 UBR4 SLC35E1 RCC1 PTBP1 ITIH2 KMT2D CCT5 CCDC47 CSNK1A1 EHD1 AFDN SLC25A11 DDX60L ATP2A2 CNP SDHA | 1.67e-09 | 711 | 185 | 20 | 33022573 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GPC1 SETD1A AARS1 ITCH CCT3 MYO6 UBR4 RECQL ABCF2 RCC1 PTBP1 ATAD2 TRRAP CCT5 CCDC47 EHD1 SMARCA2 SMARCA4 AFDN SLC25A11 DDX60L FERMT2 ATP2A2 ATP2B1 NUP160 CNP SORD | 3.67e-09 | 1353 | 185 | 27 | 29467282 |
| Pubmed | CTNNAL1 CCT3 TTC28 MYO6 ABCF2 YTHDC2 CDK5RAP3 BAIAP2L1 CCT5 CCDC47 EHD1 DOCK7 AFDN SLC25A11 FERMT2 ATP2A2 ATP2B1 CNP SDHA | 9.33e-09 | 708 | 185 | 19 | 39231216 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP6V1A AARS1 ATRX CCT3 MYO6 PUF60 SYNE1 UBR4 RECQL ABCF2 YTHDC2 RCC1 PTBP1 ATAD2 THADA CCT5 CCDC47 DOCK7 SMARCA4 AFDN SMARCE1 SLC25A11 TAF5L ATP2A2 ATP2B1 NUP160 SDHA | 1.09e-08 | 1425 | 185 | 27 | 30948266 |
| Pubmed | FKBP15 AARS1 MIA3 ITCH NUP85 MYO6 DOCK8 UBR4 MFSD6 RNF213 RECQL ABCF2 PTBP1 ELMO1 CNOT6 CDK5RAP3 CCDC47 CSNK1A1 EHD1 SMARCA4 ATP2B1 ATP2B4 CNP CKLF | 1.70e-08 | 1168 | 185 | 24 | 19946888 | |
| Pubmed | TLK2 SIN3B AARS1 CCT3 DOCK8 PUF60 RECQL RCC1 PTBP1 TRRAP PIAS1 EMSY ELMO1 KMT2D CCT5 CSNK1A1 SMARCA2 SMARCA4 SMARCE1 TAF5L ATP2A2 ZNF687 SORD | 2.65e-08 | 1103 | 185 | 23 | 34189442 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | ATRX PUF60 RECQL PTBP1 FOXA1 TRRAP PIAS1 KMT2D CSNK1A1 SMARCA2 SMARCE1 | 3.10e-08 | 220 | 185 | 11 | 35785414 |
| Pubmed | ATP6V1A NUP85 CCT3 DDX60 UBR4 SLC35E1 RNF213 RECQL ABCF2 YTHDC2 RCC1 PTBP1 THADA CNOT6L CCT5 CCDC47 NFKB1 EHD1 RWDD1 DOCK7 SLC25A11 DDX60L ATP2A2 ATP2B1 CNP SDHA | 5.46e-08 | 1440 | 185 | 26 | 30833792 | |
| Pubmed | TLK2 ATRX CCT3 EMSY CCT5 SMARCA2 SMARCA4 SMARCE1 SLC25A11 ATP2A2 | 5.80e-08 | 183 | 185 | 10 | 36129980 | |
| Pubmed | AARS1 CCT3 PUF60 UBR4 RECQL YTHDC2 FRYL ATAD2 TRRAP CCT5 DOCK7 SMARCA2 SMARCA4 AFDN ATP2A2 NUP160 SDHA | 9.02e-08 | 653 | 185 | 17 | 22586326 | |
| Pubmed | Gene and cluster-specific expression of the Iroquois family members during mouse development. | 9.56e-08 | 9 | 185 | 4 | 11520674 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP SETD1A PDE4A NUP85 PUF60 NLRX1 UBR4 FRYL INO80 TRRAP ATP13A2 FANCA THADA KMT2D SCAP PTPRF PTPRS KCNJ11 NAV2 DOCK6 SDHA ZNF687 | 1.21e-07 | 1105 | 185 | 22 | 35748872 |
| Pubmed | ATP6V1A FKBP15 AARS1 ATRX CCT3 PUF60 UBR4 RNF213 RECQL RCC1 INO80 TRRAP PIAS1 PAPOLA CCT5 CSNK1A1 SMARCA2 SMARCA4 SMARCE1 ZNF687 SORD | 1.25e-07 | 1014 | 185 | 21 | 32416067 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 1.48e-07 | 3 | 185 | 3 | 31985401 | |
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 1.48e-07 | 3 | 185 | 3 | 33656439 | |
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 9784606 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ATP6V1A AARS1 MIA3 ITCH NUP85 HGH1 MYO6 UBR4 SLC35E1 ABCF2 FANCA THADA SCAP PTPRF HOOK1 BAIAP2L1 CCDC47 ATP2A2 ATP2B4 SDHA | 1.72e-07 | 942 | 185 | 20 | 31073040 |
| Pubmed | GPC1 ATP6V1A CCT3 MYO6 DOCK8 SYNE1 YTHDC2 ITGA2 PTBP1 CSNK1A1L CCT5 PTPRS CSNK1A1 AP3B2 EHD1 DOCK7 SMARCA4 AFDN SLC25A11 FERMT2 ATP2A2 ATP2B1 ATP2B4 CNP SDHA | 1.88e-07 | 1431 | 185 | 25 | 37142655 | |
| Pubmed | 2.48e-07 | 11 | 185 | 4 | 25624497 | ||
| Pubmed | 2.48e-07 | 11 | 185 | 4 | 10926765 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | CCT3 MYO6 UBR4 RECQL YTHDC2 RCC1 TRRAP DPH6 CDK5RAP3 CCDC47 SMARCA2 SMARCA4 SMARCE1 SLC25A11 DNAH8 NUP160 SORD | 2.60e-07 | 704 | 185 | 17 | 29955894 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FKBP15 AARS1 CTNNAL1 NUP85 UBR4 ABCF2 YTHDC2 CSNK1A1L PTPRD STYX PTPRF CCT5 PTPRS CSNK1A1 LRP1 AFDN ATP2B1 NUP160 CNP SDHA | 2.92e-07 | 974 | 185 | 20 | 28675297 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SIN3B AARS1 ITCH CCT3 PUF60 UBR4 RNF213 RECQL FRYL EMSY CDK5RAP3 BAIAP2L1 CCT5 CCDC47 NFKB1 SLC25A10 SMARCA2 LRP1 AFDN SMARCE1 SLC25A11 ATP2A2 NUP160 CNP | 3.10e-07 | 1367 | 185 | 24 | 32687490 |
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 8524829 | ||
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 19781646 | ||
| Pubmed | SETD1A SIN3B ACACB ATRX CCT3 MYO6 UBR4 INO80 FOXA1 TRRAP PIAS1 EMSY KMT2D CCT5 NFKB1 SLC25A10 SMARCA2 SMARCA4 SMARCE1 SLC25A11 TAF5L ATP2A2 ZNF687 SORD | 6.82e-07 | 1429 | 185 | 24 | 35140242 | |
| Pubmed | 7.44e-07 | 14 | 185 | 4 | 12432077 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SETD1A MIA3 NUP85 ATRX DOCK11 ABCF2 YTHDC2 TRRAP SMARCA2 SMARCA4 SMG9 NUP160 ZNF687 | 7.74e-07 | 440 | 185 | 13 | 34244565 |
| Pubmed | FKBP15 GLS2 UBR4 RNF213 PTBP1 ITIH2 DOCK7 SMARCA2 SMARCA4 AFDN FERMT2 | 7.94e-07 | 304 | 185 | 11 | 32235678 | |
| Pubmed | MIA3 CCT3 MYO6 SLC35E1 RCC1 ITGA2 TMX2 SCAP CSNK1A1L CCDC47 CSNK1A1 STOML1 EHD1 SLC25A10 SLC25A11 ATP2A2 ATP2B1 ATP2B4 CNP | 8.99e-07 | 952 | 185 | 19 | 38569033 | |
| Pubmed | CTNNAL1 CCT3 TTC28 MYO6 SLC35E1 CCT5 CCDC47 SLC25A10 DOCK7 AFDN SLC25A11 FERMT2 ATP2A2 | 9.69e-07 | 449 | 185 | 13 | 31732153 | |
| Pubmed | ATP6V1A ACACB CCT3 TTC28 MYO6 RNF213 PTBP1 OTUD7B THADA BAIAP2L1 CCT5 MTFR1 EHD1 DOCK7 AFDN FERMT2 NUP160 | 1.01e-06 | 777 | 185 | 17 | 35844135 | |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | SETD1A ATP6V1A SIN3B ACACB CCT3 MYO6 ABCF2 PTBP1 PIAS1 PAPOLA CCT5 SLC25A11 TAF5L NUP160 ZNF687 | 1.43e-06 | 624 | 185 | 15 | 33729478 |
| Pubmed | 1.47e-06 | 5 | 185 | 3 | 10777529 | ||
| Pubmed | 1.47e-06 | 5 | 185 | 3 | 22357843 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.50e-06 | 202 | 185 | 9 | 33005030 | |
| Pubmed | MYT1L AARS1 RELN ITCH ATRX TTC28 MYO6 SYNE1 UBR4 DZIP1 PIAS1 RBCK1 PTPRD LRP1 CHMP3 SMARCA4 OLFM1 AFDN SMARCE1 ATP2A2 SDHA DOP1B | 1.51e-06 | 1285 | 185 | 22 | 35914814 | |
| Pubmed | 1.60e-06 | 151 | 185 | 8 | 17043677 | ||
| Pubmed | SETD1A SIN3B TTC28 PUF60 RCC1 TRRAP EMSY KMT2D CCT5 DOCK7 SMARCA4 AFDN SMARCE1 SLC25A11 | 1.64e-06 | 549 | 185 | 14 | 38280479 | |
| Pubmed | ATP6V1A MIA3 CCT3 MYO6 DOCK11 UBR4 DOCK7 SMARCA4 SMARCE1 FERMT2 DOCK6 ATP2B1 | 1.73e-06 | 399 | 185 | 12 | 37536630 | |
| Pubmed | GGNBP2 CTNNAL1 ACACB TTC28 MYO6 UBR4 ADCK2 PIAS1 KMT2D CCDC47 ASXL3 SMARCA2 SMARCE1 ATP2B1 ZNF687 | 1.88e-06 | 638 | 185 | 15 | 31182584 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | AARS1 ITCH MYO6 UBR4 ITGA2 ITIH2 THADA CCT5 EHD1 SLC25A10 SLC25A11 ATP2A2 ATP2B1 ATP2B4 SDHA | 2.23e-06 | 647 | 185 | 15 | 26618866 |
| Pubmed | 2.24e-06 | 18 | 185 | 4 | 14559996 | ||
| Pubmed | AARS1 GGNBP2 MIA3 NUP85 ATRX TTC28 SLC35E1 YTHDC2 PIAS1 FANCA SULF2 SLC25A10 DOCK7 AFDN SLC25A11 | 2.36e-06 | 650 | 185 | 15 | 38777146 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DAB2IP ITCH ITGA2 ATAD2 PTPRF BAIAP2L1 SLC15A1 CSNK1A1 EHD1 DOCK7 NAV2 FERMT2 ATP2B1 ATP2B4 | 2.48e-06 | 569 | 185 | 14 | 30639242 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ATP6V1A NUP85 CCT3 PUF60 SYNE1 ABCF2 YTHDC2 RCC1 PTBP1 TRRAP PTPRF CCT5 DOCK7 SMARCA4 AFDN ATP2A2 ATP2B1 NUP160 CNP | 2.61e-06 | 1024 | 185 | 19 | 24711643 |
| Pubmed | 2.93e-06 | 6 | 185 | 3 | 19273906 | ||
| Pubmed | 2.93e-06 | 6 | 185 | 3 | 16940996 | ||
| Pubmed | MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism. | 2.93e-06 | 6 | 185 | 3 | 33667384 | |
| Pubmed | Comparison of Iroquois gene expression in limbs/fins of vertebrate embryos. | 2.93e-06 | 6 | 185 | 3 | 20408909 | |
| Pubmed | 2.93e-06 | 6 | 185 | 3 | 11042145 | ||
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 2.93e-06 | 6 | 185 | 3 | 12767889 | |
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 2.93e-06 | 6 | 185 | 3 | 25081545 | |
| Pubmed | 2.93e-06 | 6 | 185 | 3 | 36773339 | ||
| Pubmed | Regulated expression patterns of IRX-2, an Iroquois-class homeobox gene, in the human breast. | 2.93e-06 | 6 | 185 | 3 | 10370142 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | AARS1 ACACB HGH1 MYO6 DOCK11 TOPAZ1 RECQL YTHDC2 TRRAP CCT5 SLC25A10 NAV2 ZNF687 | 2.96e-06 | 497 | 185 | 13 | 36774506 |
| Pubmed | DAB2IP CTNNAL1 ITCH ACACB DZIP1 ITGA2 BAIAP2L1 FERMT2 ATP2B1 ATP2B4 CNP SDHA | 3.01e-06 | 421 | 185 | 12 | 36976175 | |
| Pubmed | ATP6V1A COL11A1 NUP85 SYNE1 RCC1 PTBP1 TRRAP SCAP PTPRF CCT5 CSNK1A1 SMARCA4 SMARCE1 NUP160 SDHA ZNF687 | 3.15e-06 | 754 | 185 | 16 | 35906200 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SETD1A ACACB INO80 PIAS1 EMSY KMT2D ASXL3 SMARCA2 SMARCA4 SMARCE1 TAF5L | 3.19e-06 | 351 | 185 | 11 | 38297188 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SIN3B NUP85 PUF60 UBR4 RECQL RCC1 FOXA1 TRRAP EMSY KMT2D NFKB1 LRP1 SMARCA4 SMARCE1 TAF5L ATP2B1 NUP160 | 3.77e-06 | 857 | 185 | 17 | 25609649 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 3.78e-06 | 289 | 185 | 10 | 23752268 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 3.86e-06 | 120 | 185 | 7 | 31413325 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | GPC1 ITCH NUP85 CCT3 MYO6 PUF60 DDX60 RECQL ABCF2 YTHDC2 PTBP1 ITIH2 BAIAP2L1 CCT5 CSNK1A1 DOCK7 SMARCA4 SLC25A11 NUP160 CNP SDHA | 3.89e-06 | 1257 | 185 | 21 | 36526897 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AARS1 ITCH TTC28 DOCK11 FRYL DZIP1 HOOK1 BAIAP2L1 CSNK1A1 DOCK7 NAV2 FAM83G AFDN DOCK6 ATP2B1 BICC1 DOP1B | 4.00e-06 | 861 | 185 | 17 | 36931259 |
| Pubmed | Requiem protein links RelB/p52 and the Brm-type SWI/SNF complex in a noncanonical NF-kappaB pathway. | 4.32e-06 | 21 | 185 | 4 | 20460684 | |
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | ATP6V1A RNF130 AARS1 ITCH CCT3 SLC35E1 CDK5RAP3 PTPRF CCT5 PTPRS CCDC47 ATP2A2 CNP | 4.44e-06 | 516 | 185 | 13 | 36610398 |
| Pubmed | 5.10e-06 | 7 | 185 | 3 | 12376545 | ||
| Pubmed | POST, partner of stromal interaction molecule 1 (STIM1), targets STIM1 to multiple transporters. | 5.10e-06 | 7 | 185 | 3 | 22084111 | |
| Pubmed | The prepattern transcription factor Irx3 directs nephron segment identity. | 5.10e-06 | 7 | 185 | 3 | 17875669 | |
| Pubmed | 5.10e-06 | 7 | 185 | 3 | 29073098 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 5.44e-06 | 178 | 185 | 8 | 27637333 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ATP6V1A AARS1 MIA3 CCT3 PUF60 SYNE1 UBR4 RCC1 PTBP1 CCT5 CSNK1A1 SLC25A10 SLC25A11 ATP2A2 UNC79 SORD | 7.39e-06 | 807 | 185 | 16 | 30575818 |
| Pubmed | 7.80e-06 | 187 | 185 | 8 | 26460568 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SETD1A ATP6V1A NUP85 ACACB CCT3 PUF60 UBR4 RECQL ABCF2 PTBP1 EMSY CCT5 CCDC47 SLC25A10 SMARCA2 SMARCA4 SLC25A11 ATP2A2 NUP160 SDHA ZNF687 | 8.02e-06 | 1318 | 185 | 21 | 30463901 |
| Pubmed | 8.13e-06 | 8 | 185 | 3 | 37591863 | ||
| Pubmed | 8.13e-06 | 8 | 185 | 3 | 10951186 | ||
| Pubmed | 8.13e-06 | 8 | 185 | 3 | 11118473 | ||
| Pubmed | 8.13e-06 | 8 | 185 | 3 | 28637841 | ||
| Pubmed | 8.50e-06 | 250 | 185 | 9 | 33536335 | ||
| Pubmed | TTC28 MYO6 DDX60 UBR4 FOXA1 RIN2 EHD1 SMARCA2 LRP1 NAV2 SMARCA4 SMARCE1 ATP2B4 CNP | 8.51e-06 | 634 | 185 | 14 | 34591612 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | TLK2 MYO6 DOCK11 DDX60 RECQL ABCF2 YTHDC2 INO80 CCT5 DOCK7 SMG9 SLC25A11 FERMT2 ATP2A2 CNP | 8.59e-06 | 724 | 185 | 15 | 36232890 |
| Pubmed | SETD1A NUP85 ATRX CCT3 TTC28 RCC1 TRRAP KMT2D NFKB1 SMARCA4 UNC79 NUP160 | 8.95e-06 | 469 | 185 | 12 | 27634302 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | GPC1 SIN3B ATRX DOCK11 UBR4 YTHDC2 INO80 CSNK1A1L CCT5 CSNK1A1 CHMP3 SLC25A11 | 1.02e-05 | 475 | 185 | 12 | 31040226 |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 1.03e-05 | 256 | 185 | 9 | 35777956 | |
| Pubmed | Cardiomyopathy in Irx4-deficient mice is preceded by abnormal ventricular gene expression. | 1.06e-05 | 26 | 185 | 4 | 11238910 | |
| Pubmed | 1.13e-05 | 55 | 185 | 5 | 35945219 | ||
| Pubmed | 1.21e-05 | 9 | 185 | 3 | 14585979 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.27e-05 | 332 | 185 | 10 | 32786267 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | SETD1A NUP85 TRRAP KMT2D CDK5RAP3 BAIAP2L1 EHD1 DOCK7 SMARCA2 TAF5L ATP2A2 | 1.38e-05 | 410 | 185 | 11 | 26949251 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATP6V1A RNF130 MIA3 TPCN2 ITCH ATRX MYO6 RNF213 FRYL TRRAP DNAH14 THADA GUCY1A1 PTPRS CSNK1A1 TGFBRAP1 RIN2 SMARCA2 LRP1 DOCK6 ATP2B1 CKLF | 1.56e-05 | 1489 | 185 | 22 | 28611215 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RNF130 ATRX CCT3 RBM45 DOCK8 PUF60 MAGEE2 YTHDC2 PTBP1 CCT5 EHD1 SMARCA2 SMARCA4 | 1.60e-05 | 582 | 185 | 13 | 20467437 |
| Pubmed | 1.73e-05 | 10 | 185 | 3 | 14729568 | ||
| Pubmed | 1.73e-05 | 10 | 185 | 3 | 11839798 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | TLK2 ATRX MYO6 PUF60 UBR4 FRYL TRRAP RASGRP1 CDK5RAP3 CNOT6L HOOK1 PTPRS CCDC47 SMARCA4 FAM83G PYGM AFDN ATP2A2 UNC79 NUP160 | 1.85e-05 | 1284 | 185 | 20 | 17353931 |
| Pubmed | CPXM2 ATRX MYO6 DOCK8 UBR4 PIAS1 KMT2D PTPRF PAPOLA LRP1 CHMP3 AFDN SMARCE1 | 1.87e-05 | 591 | 185 | 13 | 15231748 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TLK2 ATRX YTHDC2 RCC1 ATAD2 TRRAP EMSY OTUD7B KMT2D PAPOLA SMARCA2 SMARCA4 AFDN ATP2A2 ZNF687 | 1.88e-05 | 774 | 185 | 15 | 15302935 |
| Interaction | KCNA3 interactions | ADCY10 CTNNAL1 CCT3 TTC28 MYO6 PUF60 RNF213 ABCF2 YTHDC2 PTBP1 CDK5RAP3 HOOK1 BAIAP2L1 CCT5 CCDC47 AP3B2 EHD1 DOCK7 SMARCA4 AFDN SLC25A11 FERMT2 ATP2A2 ATP2B1 CNP SDHA | 8.34e-08 | 871 | 182 | 26 | int:KCNA3 |
| Interaction | WDR5 interactions | SETD1A AARS1 FLT3 NUP85 ACACB CCT3 PUF60 UBR4 SLC35E1 RCC1 INO80 PTBP1 FOXA1 TRRAP ITIH2 KMT2D CCT5 CCDC47 CSNK1A1 ASXL3 EHD1 SMARCA2 AFDN SLC25A11 DDX60L ATP2A2 NUP160 CNP SDHA | 1.99e-07 | 1101 | 182 | 29 | int:WDR5 |
| Interaction | ELF4 interactions | 1.01e-06 | 115 | 182 | 9 | int:ELF4 | |
| Interaction | BSG interactions | GPC1 TTC28 DOCK8 NLRX1 SLC35E1 RNF213 TRRAP RBCK1 FANCA CDK5RAP3 CCDC47 SLC25A10 SLC25A11 ATP2A2 ATP2B1 ATP2B4 CNP SORD | 1.74e-05 | 631 | 182 | 18 | int:BSG |
| Interaction | CEBPA interactions | TLK2 SIN3B AARS1 ITCH CCT3 RASGRF1 DOCK8 PUF60 RECQL RCC1 PTBP1 TRRAP PIAS1 EMSY ELMO1 KMT2D CCT5 CSNK1A1 SMARCA2 SMARCA4 SMARCE1 SLC25A11 TAF5L ATP2A2 NUP160 ZNF687 SORD | 2.04e-05 | 1245 | 182 | 27 | int:CEBPA |
| Interaction | DPF3 interactions | 2.47e-05 | 95 | 182 | 7 | int:DPF3 | |
| GeneFamily | ATPases Ca2+ transporting | 2.76e-05 | 9 | 127 | 3 | 1209 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 4.10e-04 | 21 | 127 | 3 | 813 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 7.82e-04 | 26 | 127 | 3 | 526 | |
| Coexpression | LI_CISPLATIN_RESISTANCE_UP | 8.00e-07 | 26 | 178 | 5 | M4717 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP | 1.20e-06 | 200 | 178 | 10 | M3869 | |
| Coexpression | GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN | 5.84e-06 | 66 | 178 | 6 | M12812 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 9.33e-06 | 199 | 178 | 9 | M6264 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN | 1.95e-05 | 167 | 178 | 8 | M6699 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | AARS1 NUP85 CCT3 PUF60 ABCF2 RCC1 TRRAP FANCA CNOT6 CCT5 CCDC47 SMARCA4 ATP2B1 CKLF DOP1B | 2.02e-05 | 612 | 178 | 15 | M4772 |
| Coexpression | TBK1.DF_DN | ITCH MYO6 DDX60 MFSD6 IMPACT RCC1 ITGA2 HOOK1 SMARCA2 ATP2B1 | 2.78e-05 | 286 | 178 | 10 | M2864 |
| Coexpression | MODY_HIPPOCAMPUS_POSTNATAL | 3.94e-05 | 56 | 178 | 5 | M10332 | |
| Coexpression | MODY_HIPPOCAMPUS_POSTNATAL | 3.94e-05 | 56 | 178 | 5 | MM648 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | MYT1L ATP6V1A ATRX CCT3 RECQL XK DZIP1 TRRAP ATP13A2 PIAS1 ELMO1 CCT5 STOML1 AP3B2 SMARCA2 OLFM1 SLC25A11 GNG3 FERMT2 ATP2A2 ATP2B1 SDHA | 4.15e-05 | 1248 | 178 | 22 | M17728 |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 5.95e-05 | 144 | 178 | 7 | M5942 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MYT1L FKBP15 RELN COL11A1 MIA3 ATRX MFSD6 XK IRX3 IRX1 CNOT6L HOOK1 GUCY1A1 VWA5A ASXL3 AP3B2 OLFM1 ATP2B1 UNC79 DOP1B | 6.71e-05 | 1106 | 178 | 20 | M39071 |
| Coexpression | GSE14308_TH17_VS_INDUCED_TREG_UP | 7.04e-05 | 200 | 178 | 8 | M3385 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TLK2 ITCH ATRX TTC28 FRYL TRRAP LPAR1 CSNK1A1 MTFR1 RIN2 NFKB1 SMARCA2 FERMT2 ATP2B1 ATP2B4 NUP160 DOP1B | 7.95e-05 | 856 | 178 | 17 | M4500 |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | AARS1 COL11A1 CTNNAL1 IMPACT FRYL PKDREJ IRX4 PTPRF SLC25A10 NAV2 SMARCA4 ATP2A2 BICC1 DOP1B | 8.47e-05 | 615 | 178 | 14 | M8673 |
| Coexpression | PILON_KLF1_TARGETS_UP | COL11A1 CTNNAL1 SLC38A4 XK FRYL EMSY ITIH2 CSNK1A1L PTPRD PTPRF GUCY1A1 CSNK1A1 FERMT2 | 8.92e-05 | 541 | 178 | 13 | MM1061 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 9.25e-05 | 208 | 178 | 8 | MM581 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | GGNBP2 PDE4A ACACB TTC28 MYO6 DDX60 RECQL TRRAP MTFR1 LRP1 SMARCA4 OLFM1 ATP2A2 ATP2B1 SDHA SORD | 1.04e-04 | 790 | 178 | 16 | M12490 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN | 1.14e-04 | 37 | 178 | 4 | MM570 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | TLK2 SETD1A ATP6V1A GGNBP2 COL11A1 ITCH ATRX CCT3 RBM45 DOCK11 RNF213 ABCF2 YTHDC2 IRX3 CNOT6 CNOT6L HOOK1 CSNK1A1 ASXL3 MTFR1 NAV2 SMARCA4 ATP2B1 | 2.58e-07 | 804 | 177 | 23 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | DAB2IP TLK2 SETD1A GGNBP2 COL11A1 ITCH ATRX RBM45 DOCK11 FAT3 CNOT6 SULF2 CNOT6L PAPOLA GUCY1A1 ASXL3 SMARCA2 LRP1 NAV2 SMARCA4 ATP2B1 BICC1 | 9.48e-07 | 801 | 177 | 22 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | SLC38A4 FAT3 IMPACT DZIP1 LPAR1 SULF2 PTPRD GUCY1A1 ASXL3 LRP1 ARMCX6 SMARCE1 ATP2B4 BICC1 | 9.61e-07 | 337 | 177 | 14 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | TLK2 SETD1A GGNBP2 COL11A1 ITCH ATRX RBM45 DOCK11 FAT3 CNOT6L ASXL3 LRP1 NAV2 ATP2B1 BICC1 | 1.68e-06 | 406 | 177 | 15 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | SLC38A4 FAT3 IMPACT DZIP1 LPAR1 IER2 GUCY1A1 ASXL3 SMARCA2 LRP1 ARMCX6 SMARCE1 BICC1 | 9.05e-06 | 354 | 177 | 13 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | TLK2 SETD1A GGNBP2 COL11A1 ITCH ATRX RBM45 DOCK11 FAT3 CNOT6L ASXL3 LRP1 ATP2B1 BICC1 | 1.01e-05 | 413 | 177 | 14 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | TLK2 SETD1A GGNBP2 ITCH ATRX CCT3 RBM45 DOCK11 RNF213 CNOT6 SULF2 CNOT6L HOOK1 PAPOLA GUCY1A1 ASXL3 NAV2 SMARCA4 ATP2B1 BICC1 | 1.37e-05 | 806 | 177 | 20 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | FAT3 IMPACT RNF213 IRX3 DZIP1 LPAR1 RASGRP1 SULF2 PTPRD PTPRF GUCY1A1 ASXL3 RIN2 LRP1 NAV2 ARMCX6 CCDC171 ATP2B4 CKLF | 1.42e-05 | 740 | 177 | 19 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 1.89e-05 | 136 | 177 | 8 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | COL11A1 DOCK11 SLC38A4 DZIP1 LPAR1 GGTA1 PTPRD VWA5A ASXL3 RIN2 SMARCA2 | 3.15e-05 | 288 | 177 | 11 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | DAB2IP TLK2 SETD1A GGNBP2 COL11A1 ITCH ATRX RBM45 DOCK11 FAT3 CNOT6 CNOT6L VWA5A ASXL3 SMARCA2 LRP1 NAV2 ATP2B1 BICC1 | 3.49e-05 | 790 | 177 | 19 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | FAT3 LPAR1 SULF2 PTPRD GUCY1A1 ASXL3 LRP1 ARMCX6 PYGM ATP2B4 BICC1 | 6.13e-05 | 310 | 177 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.71e-05 | 209 | 177 | 9 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 7.51e-05 | 165 | 177 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 7.84e-05 | 166 | 177 | 8 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | FAT3 IMPACT DZIP1 LPAR1 SULF2 GUCY1A1 ASXL3 LRP1 ARMCX6 ATP2B4 | 8.00e-05 | 265 | 177 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | MYT1L TLK2 SETD1A GGNBP2 ITCH ATRX RBM45 DOCK11 RNF213 YTHDC2 IRX3 RASGRP1 CNOT6L HOOK1 GUCY1A1 NAV2 SMARCA4 DNAH8 | 1.21e-04 | 795 | 177 | 18 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | FAT3 RNF213 IRX3 DZIP1 LPAR1 SULF2 DNAJC28 BAIAP2L1 GUCY1A1 PTPRS ASXL3 LRP1 NAV2 ARMCX6 OLFM1 CCDC171 ATP2B4 BICC1 | 1.25e-04 | 797 | 177 | 18 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.30e-04 | 281 | 177 | 10 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | SIN3B CTNNAL1 SH3GL2 RNF213 TRRAP ELMO1 TMX2 SCAP PTPRD DNAJC28 PTPRF HOOK1 RIN2 DOCK7 NAV2 PPP1R36 CCDC171 ATP2A2 CNP | 1.53e-04 | 884 | 177 | 19 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.60e-04 | 184 | 177 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+F4/80lo.Kd, CD45+ CD11c+ I-A/I-E+ CD11b+ F4/80lo, Kidney, avg-3 | FLT3 GPR141 ABCA9 NLRC4 SULF2 VWA5A RIN2 DOCK7 LRP1 OLFM1 AFDN LTB4R | 1.61e-04 | 406 | 177 | 12 | GSM854273_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | TLK2 SETD1A GGNBP2 ITCH ATRX CCT3 RBM45 DOCK11 RNF213 IRX3 ASXL3 NAV2 | 1.72e-04 | 409 | 177 | 12 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | SLC38A4 FAT3 IMPACT RNF213 DZIP1 LPAR1 SULF2 PTPRD GUCY1A1 ASXL3 RIN2 LRP1 ARMCX6 SMARCE1 ADGRF5 ATP2B1 ATP2B4 BICC1 | 1.98e-04 | 827 | 177 | 18 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | FAT3 RNF213 ATAD2 LPAR1 SULF2 PTPRD PTPRF GUCY1A1 ASXL3 DOCK7 LRP1 ARMCX6 PYGM PPP1R36 CCDC171 ATP2B4 BICC1 | 2.46e-04 | 768 | 177 | 17 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 2.69e-04 | 150 | 177 | 7 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 2.91e-04 | 152 | 177 | 7 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2 | 3.17e-04 | 71 | 177 | 5 | GSM605878_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 3.55e-04 | 207 | 177 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | TLK2 SETD1A GGNBP2 COL11A1 ITCH ATRX RBM45 DOCK11 FAT3 GGTA1 CNOT6L ASXL3 SMARCA2 LRP1 NAV2 ATP2B1 BICC1 | 3.88e-04 | 799 | 177 | 17 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | SIN3B CTNNAL1 SH3GL2 RNF213 TRRAP ELMO1 TMX2 SCAP PTPRD DNAJC28 PTPRF HOOK1 BAIAP2L1 RIN2 DOCK7 NAV2 PPP1R36 CCDC171 | 4.17e-04 | 880 | 177 | 18 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | MYT1L TLK2 SETD1A GGNBP2 ITCH ATRX RBM45 DOCK11 RNF213 IRX3 RASGRP1 | 4.20e-04 | 387 | 177 | 11 | gudmap_developingGonad_e16.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 4.28e-04 | 162 | 177 | 7 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | SLC38A4 IMPACT LPAR1 IER2 SULF2 GUCY1A1 PTPRS ASXL3 LRP1 ARMCX6 | 4.35e-04 | 327 | 177 | 10 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_200 | 4.36e-04 | 76 | 177 | 5 | gudmap_developingGonad_e16.5_epididymis_200_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#5 | RELN CTNNAL1 MFSD6 FOXA1 THADA CDH20 BAIAP2L1 NAV2 CCDC171 ATP2B1 | 4.46e-04 | 328 | 177 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | TLK2 SETD1A GGNBP2 COL11A1 ITCH ATRX CCT3 RBM45 DOCK11 ABCF2 YTHDC2 CNOT6 CNOT6L HOOK1 ASXL3 MTFR1 SMARCA4 | 4.86e-04 | 815 | 177 | 17 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 4.95e-04 | 166 | 177 | 7 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 5.13e-04 | 167 | 177 | 7 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.32e-04 | 168 | 177 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.37e-04 | 121 | 177 | 6 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.46e-04 | 277 | 177 | 9 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | TLK2 SETD1A GGNBP2 ITCH ATRX RBM45 CNOT6L ASXL3 NAV2 SMARCA4 ATP2B1 | 5.89e-04 | 403 | 177 | 11 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | TLK2 SETD1A GGNBP2 COL11A1 ITCH ATRX RBM45 FAT3 CNOT6L ATP2B1 BICC1 | 6.01e-04 | 404 | 177 | 11 | gudmap_developingGonad_e18.5_epididymis_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | SLC38A4 FAT3 IMPACT RNF213 DZIP1 LPAR1 ZRANB3 IER2 GUCY1A1 ASXL3 SMARCA2 LRP1 ARMCX6 SMARCE1 ADGRF5 ATP2B1 BICC1 | 6.04e-04 | 831 | 177 | 17 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | 6.53e-04 | 83 | 177 | 5 | GSM476663_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 6.78e-04 | 175 | 177 | 7 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#3_top-relative-expression-ranked_100 | 6.80e-04 | 5 | 177 | 2 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k3_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_100 | 6.90e-04 | 84 | 177 | 5 | gudmap_developingGonad_e14.5_ epididymis_100 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3 | FLT3 GPR141 ABCA9 NLRC4 SULF2 VWA5A RIN2 DOCK7 LRP1 OLFM1 ATP2B1 | 6.92e-04 | 411 | 177 | 11 | GSM605872_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 7.83e-04 | 130 | 177 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | TLK2 SETD1A GGNBP2 ITCH ATRX CCT3 RBM45 DOCK11 RNF213 YTHDC2 IRX3 RASGRP1 CNOT6L HOOK1 NAV2 DNAH8 | 8.06e-04 | 776 | 177 | 16 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | MYT1L TLK2 SETD1A GGNBP2 ITCH ATRX RBM45 RNF213 YTHDC2 IRX3 RASGRP1 CNOT6L HOOK1 GUCY1A1 MTFR1 NAV2 | 8.28e-04 | 778 | 177 | 16 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | FAT3 IMPACT RNF213 IRX3 DZIP1 SULF2 PTPRD PTPRF GUCY1A1 ASXL3 RIN2 LRP1 NAV2 ARMCX6 CCDC171 CKLF | 8.86e-04 | 783 | 177 | 16 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#3 | 8.89e-04 | 238 | 177 | 8 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K3 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN MIA3 ATRX TTC28 MYO6 FRYL GRIN2C PTPRF NAV2 ATP2A2 ATP2B1 | 6.37e-10 | 195 | 185 | 11 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN MIA3 ATRX TTC28 MYO6 FRYL GRIN2C PTPRF NAV2 ATP2A2 ATP2B1 | 6.37e-10 | 195 | 185 | 11 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | droplet-Lung-nan-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-07 | 190 | 185 | 9 | b057bea6e55cef872290893b6e439bbcdcee2f2e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.28e-07 | 194 | 185 | 9 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.34e-07 | 195 | 185 | 9 | ce1ba5911e8a6ddb07434acc37147c38e94245ff | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 186 | 185 | 8 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.15e-06 | 186 | 185 | 8 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-06 | 188 | 185 | 8 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-06 | 189 | 185 | 8 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 189 | 185 | 8 | ca657353f2b649530809c0bc057e448adc511ec1 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 189 | 185 | 8 | e5325f1c7430b574947f8ee67e425455b60dc518 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.35e-06 | 190 | 185 | 8 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-06 | 190 | 185 | 8 | 059beca1c92181b8ba4dcd6fc71ff7530d83d0de | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-06 | 190 | 185 | 8 | a51405f8466fc6d4087873137472619b2e84c1da | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-06 | 191 | 185 | 8 | caed913e7ede9f8ae3af273d1ecf375de6c5e813 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.40e-06 | 191 | 185 | 8 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.46e-06 | 192 | 185 | 8 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 192 | 185 | 8 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | 11.5-Airway-Epithelial-Bud_tip_progenitor|Airway / Age, Tissue, Lineage and Cell class | 1.51e-06 | 193 | 185 | 8 | f0a07bb221a497a9f7cc706045d5205269be4515 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.51e-06 | 193 | 185 | 8 | 4b8202fcfe639a73f69a13f48fc3601ade256346 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.64e-06 | 195 | 185 | 8 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.64e-06 | 195 | 185 | 8 | 62d369a8af2b76a2553bc8ff9cb89a133b060123 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.64e-06 | 195 | 185 | 8 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.70e-06 | 196 | 185 | 8 | 0a34a0009f479384f1994c6f977f942699a132c8 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.70e-06 | 196 | 185 | 8 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.77e-06 | 197 | 185 | 8 | 6852a8ec1397811bbdd1fc625c52ed4fa75a931e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.98e-06 | 200 | 185 | 8 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.98e-06 | 200 | 185 | 8 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.98e-06 | 200 | 185 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.98e-06 | 200 | 185 | 8 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-06 | 151 | 185 | 7 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.73e-06 | 164 | 185 | 7 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.25e-06 | 170 | 185 | 7 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 175 | 185 | 7 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 175 | 185 | 7 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 179 | 185 | 7 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.26e-05 | 185 | 185 | 7 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.30e-05 | 186 | 185 | 7 | 855c2e5a8a6cf94c7de31982e0e2416f924439d3 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.30e-05 | 186 | 185 | 7 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.35e-05 | 187 | 185 | 7 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.35e-05 | 187 | 185 | 7 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.35e-05 | 187 | 185 | 7 | c2940aec30b3c2c113f6a65126dc6f1969cf301e | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.35e-05 | 187 | 185 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-05 | 187 | 185 | 7 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.39e-05 | 188 | 185 | 7 | ed92cddf47defea2f904d36c7ae05ffa323349a9 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 188 | 185 | 7 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 188 | 185 | 7 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.39e-05 | 188 | 185 | 7 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 188 | 185 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 189 | 185 | 7 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.44e-05 | 189 | 185 | 7 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 190 | 185 | 7 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 191 | 185 | 7 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 191 | 185 | 7 | 629007189034ee8451411428f1c6cc57daee2d91 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-05 | 191 | 185 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.55e-05 | 191 | 185 | 7 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 191 | 185 | 7 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.55e-05 | 191 | 185 | 7 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.60e-05 | 192 | 185 | 7 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.60e-05 | 192 | 185 | 7 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.60e-05 | 192 | 185 | 7 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-05 | 192 | 185 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.60e-05 | 192 | 185 | 7 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-05 | 193 | 185 | 7 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.65e-05 | 193 | 185 | 7 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.65e-05 | 193 | 185 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.65e-05 | 193 | 185 | 7 | ab78fb1603ea6f720ba2d30148fe65dccf271fe1 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.65e-05 | 193 | 185 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-05 | 194 | 185 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 1.71e-05 | 194 | 185 | 7 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-05 | 194 | 185 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.71e-05 | 194 | 185 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 1.71e-05 | 194 | 185 | 7 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.71e-05 | 194 | 185 | 7 | c011cd59bb4ca4134331cba0f5d73bdbd7011d64 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.71e-05 | 194 | 185 | 7 | acd5ba9a097595d4caab4f05440531c65a4aa7bc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-05 | 194 | 185 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.77e-05 | 195 | 185 | 7 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-05 | 195 | 185 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.77e-05 | 195 | 185 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.77e-05 | 195 | 185 | 7 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-05 | 195 | 185 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.77e-05 | 195 | 185 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.77e-05 | 195 | 185 | 7 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-05 | 195 | 185 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 11.5-Distal-Epithelial-Bud_tip_progenitor|Distal / Age, Tissue, Lineage and Cell class | 1.83e-05 | 196 | 185 | 7 | 42eae265e2f2082983d8c2607c7f6a53a526d124 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.83e-05 | 196 | 185 | 7 | 75e9e430a4f55ef10f2e3132afa690fc8bfaff83 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-05 | 196 | 185 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 196 | 185 | 7 | 9f39cb3de886283da34ee7511a92d94930a6c851 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.83e-05 | 196 | 185 | 7 | 7b17d47b7758d8ccf9dbefd097aeb553791a1eed | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.83e-05 | 196 | 185 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.83e-05 | 196 | 185 | 7 | 00bef0e47739932fd1da109cd607de0789d14ca5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.89e-05 | 197 | 185 | 7 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.89e-05 | 197 | 185 | 7 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 197 | 185 | 7 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.89e-05 | 197 | 185 | 7 | 2f91b3870a7058168093a143110954c07588cfe9 | |
| ToppCell | 11.5-Distal-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 1.89e-05 | 197 | 185 | 7 | ae9505ae7e6c5e8c280f9bfb1ba79ab5bd8895e3 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.89e-05 | 197 | 185 | 7 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| Drug | copper cyanide | 2.79e-06 | 13 | 184 | 4 | CID000011009 | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.64e-06 | 196 | 184 | 10 | 2056_DN | |
| Disease | Vasodilators used in cardiac diseases use measurement | 1.87e-06 | 34 | 179 | 5 | EFO_0009926 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.18e-06 | 5 | 179 | 3 | C3281201 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.80e-05 | 9 | 179 | 3 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 3.41e-05 | 100 | 179 | 6 | C0010606 | |
| Disease | Coffin-Siris syndrome | 6.00e-05 | 13 | 179 | 3 | C0265338 | |
| Disease | coronary artery disease, factor VII measurement | 6.12e-05 | 111 | 179 | 6 | EFO_0001645, EFO_0004619 | |
| Disease | factor VIII measurement, coronary artery disease | 6.77e-05 | 113 | 179 | 6 | EFO_0001645, EFO_0004630 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 8.61e-05 | 118 | 179 | 6 | EFO_0001645, EFO_0004629 | |
| Disease | bilirubin measurement | COL11A1 MROH2A RECQL IRX1 EPX SCAP HOOK1 BAIAP2L1 DOCK7 CCDC171 ATP2B4 | 8.77e-05 | 442 | 179 | 11 | EFO_0004570 |
| Disease | pursuit maintenance gain measurement | 1.08e-04 | 123 | 179 | 6 | EFO_0008433 | |
| Disease | coronary artery disease | DAB2IP MIA3 GLS2 DOCK8 RNF213 IRX1 INO80 OTUD7B THADA SLC15A1 GUCY1A1 GPR149 STOML1 LRP1 SMARCA4 DOCK6 ATP2B1 NUP160 BICC1 | 1.26e-04 | 1194 | 179 | 19 | EFO_0001645 |
| Disease | myocardial infarction | DAB2IP MIA3 IRX1 THADA SLC15A1 GUCY1A1 SMARCA4 ATP2A2 ATP2B1 | 3.04e-04 | 350 | 179 | 9 | EFO_0000612 |
| Disease | Moyamoya disease (is_implicated_in) | 3.62e-04 | 5 | 179 | 2 | DOID:13099 (is_implicated_in) | |
| Disease | urate measurement, bone density | DAB2IP TTC28 SYNE1 GRIN2C DNAH14 RBCK1 FANCA PTPRD GPR149 OLFM1 DNAH8 ATP2B4 | 4.23e-04 | 619 | 179 | 12 | EFO_0003923, EFO_0004531 |
| Disease | irritable bowel syndrome symptom measurement | 4.30e-04 | 58 | 179 | 4 | EFO_0021536 | |
| Disease | blood urea nitrogen measurement | GGNBP2 TPCN2 SLC38A4 XK PTBP1 FANCA CDH20 SLC15A1 CCDC171 BICC1 | 4.66e-04 | 452 | 179 | 10 | EFO_0004741 |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 5.40e-04 | 6 | 179 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | triglyceride measurement, response to escitalopram, response to citalopram | 5.77e-04 | 27 | 179 | 3 | EFO_0004530, EFO_0006329, EFO_0007871 | |
| Disease | azoospermia (implicated_via_orthology) | 5.77e-04 | 27 | 179 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | myeloid white cell count | FKBP15 FLT3 COL11A1 TTC28 DOCK8 THADA BAIAP2L1 GUCY1A1 TGFBRAP1 NFKB1 OLFM1 ADGRF5 ATP2A2 ATP2B4 NUP160 | 6.24e-04 | 937 | 179 | 15 | EFO_0007988 |
| Disease | factor XI measurement, coronary artery disease | 6.96e-04 | 115 | 179 | 5 | EFO_0001645, EFO_0004694 | |
| Disease | Paraganglioma | 7.53e-04 | 7 | 179 | 2 | cv:C0030421 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 7.53e-04 | 7 | 179 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | Angle Closure Glaucoma | 7.53e-04 | 7 | 179 | 2 | C0017605 | |
| Disease | paraganglioma (is_implicated_in) | 7.53e-04 | 7 | 179 | 2 | DOID:0050773 (is_implicated_in) | |
| Disease | testosterone measurement | PDE4A MIA3 TTC28 SLC38A4 IRX1 PKDREJ NLRC4 IFNW1 THADA PTPRF BAIAP2L1 TGFBRAP1 RIN2 NFKB1 SMARCA2 ATP2B4 NUP160 SORD | 7.88e-04 | 1275 | 179 | 18 | EFO_0004908 |
| Disease | hepatocellular carcinoma (is_implicated_in) | 8.57e-04 | 181 | 179 | 6 | DOID:684 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | GPC1 COL11A1 SYNE1 UBR4 RECQL FOXA1 PKDREJ LPAR1 EMSY KMT2D SULF2 CDH20 PTPRD HOOK1 CCT5 NMBR | 8.86e-04 | 1074 | 179 | 16 | C0006142 |
| Disease | angina pectoris | 1.01e-03 | 125 | 179 | 5 | EFO_0003913 | |
| Disease | age at menarche | FLT3 COL11A1 TTC28 MYO6 INO80 SULF2 PTPRD TGFBRAP1 LRRC53 SMARCA2 UNC79 | 1.06e-03 | 594 | 179 | 11 | EFO_0004703 |
| Disease | choline measurement | 1.21e-03 | 130 | 179 | 5 | EFO_0010116 | |
| Disease | Antihypertensive use measurement | 1.22e-03 | 265 | 179 | 7 | EFO_0009927 | |
| Disease | cup-to-disc ratio measurement | 1.31e-03 | 430 | 179 | 9 | EFO_0006939 | |
| Disease | neutrophil percentage of leukocytes | FLT3 DOCK8 SH2D3C EMSY ELMO1 THADA BAIAP2L1 TGFBRAP1 NFKB1 OLFM1 NUP160 | 1.31e-03 | 610 | 179 | 11 | EFO_0007990 |
| Disease | heart disease (implicated_via_orthology) | 1.58e-03 | 38 | 179 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | theophylline measurement | 1.59e-03 | 10 | 179 | 2 | EFO_0021180 | |
| Disease | Intellectual Disability | 1.71e-03 | 447 | 179 | 9 | C3714756 | |
| Disease | stomach cancer (is_marker_for) | 1.78e-03 | 142 | 179 | 5 | DOID:10534 (is_marker_for) | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.79e-03 | 364 | 179 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | systemic scleroderma | 1.81e-03 | 85 | 179 | 4 | EFO_0000717 | |
| Disease | cholesteryl ester 18:3 measurement | 1.84e-03 | 40 | 179 | 3 | EFO_0010346 | |
| Disease | valine measurement | 1.84e-03 | 40 | 179 | 3 | EFO_0009792 | |
| Disease | primary angle closure glaucoma | 1.94e-03 | 11 | 179 | 2 | EFO_1001506 | |
| Disease | interleukin-22 receptor subunit alpha-2 measurement | 1.94e-03 | 11 | 179 | 2 | EFO_0020500 | |
| Disease | cardiovascular disease | 1.99e-03 | 457 | 179 | 9 | EFO_0000319 | |
| Disease | Thyroid preparation use measurement | 2.16e-03 | 217 | 179 | 6 | EFO_0009933 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.32e-03 | 12 | 179 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | hyperinsulinism (is_implicated_in) | 2.32e-03 | 12 | 179 | 2 | DOID:2018 (is_implicated_in) | |
| Disease | 11beta-hydroxyandrosterone glucuronide measurement | 2.32e-03 | 12 | 179 | 2 | EFO_0800573 | |
| Disease | nevus count, cutaneous melanoma | 2.32e-03 | 91 | 179 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | fibrinogen measurement, coronary artery disease | 2.54e-03 | 154 | 179 | 5 | EFO_0001645, EFO_0004623 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.58e-03 | 45 | 179 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Malignant neoplasm of salivary gland | 2.58e-03 | 45 | 179 | 3 | C0220636 | |
| Disease | COVID-19, coronary artery disease | 2.73e-03 | 13 | 179 | 2 | EFO_0001645, MONDO_0100096 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 2.73e-03 | 13 | 179 | 2 | OBA_2045159 | |
| Disease | colon carcinoma (is_marker_for) | 2.73e-03 | 13 | 179 | 2 | DOID:1520 (is_marker_for) | |
| Disease | Salivary Gland Neoplasms | 2.93e-03 | 47 | 179 | 3 | C0036095 | |
| Disease | RS-10-hydroxywarfarin measurement | 3.04e-03 | 98 | 179 | 4 | EFO_0803330 | |
| Disease | body fat percentage | 3.08e-03 | 488 | 179 | 9 | EFO_0007800 | |
| Disease | total lipids in lipoprotein particles measurement | 3.11e-03 | 48 | 179 | 3 | EFO_0022309 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.30e-03 | 49 | 179 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | cortical thickness | RELN COL11A1 GLS2 FAT3 ATP13A2 LPAR1 THADA SULF2 CDH20 PTPRF NFKB1 DOCK7 LRP1 NAV2 CCDC171 | 3.34e-03 | 1113 | 179 | 15 | EFO_0004840 |
| Disease | waist-hip ratio | COL11A1 GLS2 NUP85 TTC28 YTHDC2 IRX1 ATP13A2 THADA CDK5RAP3 PTPRD PTPRS ADGRF5 NMBR DOCK6 CCDC171 ATP2B4 | 3.37e-03 | 1226 | 179 | 16 | EFO_0004343 |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 4.12e-03 | 53 | 179 | 3 | C1961099 | |
| Disease | decreased susceptibility to hepatitis C infection | 4.15e-03 | 16 | 179 | 2 | EFO_0010101 | |
| Disease | lung small cell carcinoma (is_marker_for) | 4.15e-03 | 16 | 179 | 2 | DOID:5409 (is_marker_for) | |
| Disease | T-Cell Lymphoma | 4.15e-03 | 16 | 179 | 2 | C0079772 | |
| Disease | non-high density lipoprotein cholesterol measurement | GGNBP2 PDE4A PTBP1 EPX ABCA9 ZRANB3 RBCK1 THADA HOOK1 DOCK7 SMARCA4 | 4.34e-03 | 713 | 179 | 11 | EFO_0005689 |
| Disease | theta wave measurement | 4.69e-03 | 17 | 179 | 2 | EFO_0006873 | |
| Disease | sphingomyelin 14:0 measurement | 4.69e-03 | 17 | 179 | 2 | EFO_0010390 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 4.69e-03 | 17 | 179 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | 4.94e-03 | 525 | 179 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.94e-03 | 525 | 179 | 9 | C1257931 | |
| Disease | Mammary Neoplasms | 5.06e-03 | 527 | 179 | 9 | C1458155 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 5.25e-03 | 18 | 179 | 2 | OBA_2045155 | |
| Disease | urate measurement, spine bone mineral density | 5.30e-03 | 58 | 179 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | Drug habituation | 5.37e-03 | 115 | 179 | 4 | C0013170 | |
| Disease | Drug abuse | 5.37e-03 | 115 | 179 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 5.37e-03 | 115 | 179 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 5.37e-03 | 115 | 179 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 5.37e-03 | 115 | 179 | 4 | C0013222 | |
| Disease | Drug Dependence | 5.37e-03 | 115 | 179 | 4 | C1510472 | |
| Disease | Substance Dependence | 5.37e-03 | 115 | 179 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 5.37e-03 | 115 | 179 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 5.37e-03 | 115 | 179 | 4 | C0029231 | |
| Disease | Substance abuse problem | 5.53e-03 | 116 | 179 | 4 | C0740858 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 5.56e-03 | 59 | 179 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | Breast Carcinoma | 5.77e-03 | 538 | 179 | 9 | C0678222 | |
| Disease | neuroimaging measurement | RELN COL11A1 CTNNAL1 TPCN2 ITCH FAT3 FRYL ATP13A2 LPAR1 OTUD7B THADA SULF2 SMARCA2 NAV2 | 5.80e-03 | 1069 | 179 | 14 | EFO_0004346 |
| Disease | etiocholanolone glucuronide measurement | 5.85e-03 | 19 | 179 | 2 | EFO_0800362 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 5.88e-03 | 118 | 179 | 4 | EFO_0010119 | |
| Disease | HMG CoA reductase inhibitor use measurement | 6.04e-03 | 189 | 179 | 5 | EFO_0009932 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RISETTMLQSGMKVQ | 476 | P55196 | |
| KTLQKMMASGLTERV | 361 | Q9UG63 | |
| MAMLVTQARKNTITL | 546 | Q7Z695 | |
| SVLMGMKNQLAVLRV | 86 | Q9Y3E7 | |
| MQVVKEQVMRALTTK | 481 | Q92556 | |
| LFVIVVTTNLEQMMK | 301 | Q7RTX7 | |
| MATLMALIVKSAQIV | 281 | Q8IUA7 | |
| GSEMMAVTQKIVQVI | 201 | Q9Y3Q7 | |
| QLASTRIMTLEKEMT | 1211 | Q6TFL3 | |
| REMISSNIQAMIIKV | 151 | Q7L8W6 | |
| KDRTIMLMGVSSQKI | 646 | O95267 | |
| EISIKVMVQDMLTGI | 86 | Q8WYK0 | |
| VMVQDMLTGIEKLVS | 91 | Q8WYK0 | |
| VAMQKMIPASQRAVT | 681 | Q6PL18 | |
| MMIKTLATLVESNIF | 856 | Q96PN6 | |
| VQMAIIMGLKQTLSN | 476 | A1A5B4 | |
| MVTLLVAKAMGAAQV | 186 | Q00796 | |
| TQQEVKLRMTGMALR | 36 | Q9UBX3 | |
| MIMSVLDTKSNRVTL | 121 | Q9H694 | |
| LLISMTVINNMLAKS | 221 | Q7L4S7 | |
| KTGTLTMNRMTVVQA | 476 | P20020 | |
| KTGTLTMNRMTVVQA | 466 | P23634 | |
| VSMMVNKTVPRVVLT | 171 | Q9C0F0 | |
| MVIGTMLVKDVIQAL | 1066 | Q13367 | |
| ILVSVEVMRQSVKRM | 151 | Q06432 | |
| FTLSKTNMARIREIM | 716 | Q8N436 | |
| MMGKQLENRVVLSVS | 391 | P18754 | |
| LLRKMATQMVAAQLA | 331 | Q8IUH3 | |
| KNISVQMTIAVGTRM | 171 | Q86XS8 | |
| IMLAIITKMTLTQVS | 176 | P78413 | |
| LLVKMNTRSVTTMAV | 41 | Q7Z602 | |
| TTSSLMNLVMQFRKV | 801 | Q9ULG1 | |
| LKVARQSLTMFVLIM | 826 | O00763 | |
| GIRNKSSMVVIDVKM | 1101 | Q6IE37 | |
| MAKNNLTRVTEFILM | 1 | Q8NGQ6 | |
| EVMQSLSILRTAMQG | 591 | Q6GQQ9 | |
| DIQMKGIISRLMSVE | 1096 | Q5VWQ8 | |
| NIMLVKIFITNSAMR | 61 | P28336 | |
| SRTDPLIMKTNMLVQ | 106 | O15480 | |
| PITKADMLRNVTQMS | 131 | Q96LZ2 | |
| RSIALVNFMRMKSQT | 91 | Q8TD90 | |
| LIQRMGMTVIKQITD | 11 | Q9NPP4 | |
| ITSRMATTMIQSKVV | 81 | P19823 | |
| GMLKQQDLSIAMVVT | 61 | Q9H3C7 | |
| ITKPDMTIRQQIMQL | 446 | P35052 | |
| VAARQTTEMLKVMLQ | 426 | Q9BYM8 | |
| MLTQISQMTLKGITK | 1096 | A6NM62 | |
| VVLRNSTTLVMHMKV | 1821 | Q07954 | |
| VLIRIMMQLVSVAKS | 1351 | Q9Y3R5 | |
| DTMMSLLKTVVIVLG | 251 | Q92633 | |
| LSIAVQVMKRIHSLM | 666 | Q8IY21 | |
| ISKDLSIAVQMMKRI | 646 | Q5H9U9 | |
| RMMRPVSDQVQIKVT | 236 | Q96A33 | |
| INMVQMTFLKLLTAS | 1691 | P12107 | |
| RKSMIISATIHMQVV | 206 | Q14654 | |
| QMTEQVRSICKILAM | 461 | Q9BW27 | |
| KMLVDQVMSQRAISF | 71 | P0C7T2 | |
| NEARKIMGAMVQIIT | 416 | P11678 | |
| QSLRKMVIDMVLATD | 531 | P27815 | |
| LKIGVVLSTMAMITN | 6 | Q99784 | |
| RMTSLFIKVTNQMVT | 281 | Q96JB1 | |
| VQSVISLIMGMKFFR | 216 | O94915 | |
| RTILGTIMNTIKMVT | 911 | Q5T1M5 | |
| VMMAQILRSHLIKAT | 6 | Q9NX36 | |
| MSIGQARKMVEQLKI | 11 | P63215 | |
| MVNAGAIVVSSLIKM | 266 | Q9UI32 | |
| KTVLMLADQMISRIE | 111 | Q8N752 | |
| MVGKSREAVAQAMVL | 566 | Q86UT6 | |
| TIVPKMLVDQVMSQR | 76 | Q8NH04 | |
| RNKSSMVVIDVKMLS | 1341 | Q6IE36 | |
| GVLMTMALIVATQFR | 376 | Q6ZSS7 | |
| LMEILNVKNVMVVVS | 251 | Q9P2X3 | |
| VTEMKTNMSLGLILT | 106 | P17301 | |
| LMTVNTLQGKKMIES | 11 | A6NF36 | |
| ASMPVDIAKTRIQNM | 236 | Q02978 | |
| RMQKRSVTALMVLNL | 46 | Q15722 | |
| RASKIMFVLQIGSMS | 3326 | P78509 | |
| RNVQARMLSATTMIV | 431 | Q13332 | |
| NNSTIVVMLTKLREM | 1771 | Q13332 | |
| ISLLKMQNRTVVSML | 56 | Q86SP6 | |
| VSTRMVMVEEFKQGL | 331 | P51003 | |
| KRLIRMVFQQVGVSM | 6 | Q15390 | |
| ISLITMAIQQAPSKM | 176 | P55317 | |
| MGSLTMKSQLQITVI | 11 | Q96J02 | |
| QNRGVVSMVILKMTE | 121 | P36888 | |
| MTSGVKQKIMSVIRE | 536 | P16615 | |
| QSQTLRDMVKLSMRV | 281 | Q9NQ11 | |
| TKQQMLISCVQRILM | 2396 | P46100 | |
| VVRMEIMKSLFLSTN | 166 | P05000 | |
| IMKSLFLSTNMQERL | 171 | P05000 | |
| LQRSVSVATGLNMMK | 326 | Q9UHR4 | |
| AMLLKIQEMGSTVEV | 236 | Q8NCX0 | |
| LTKRIRTVLMATAQM | 1576 | Q5JSL3 | |
| RVKMQVTMSLSSLVG | 1501 | Q96HP0 | |
| ARVKMQVTMSLSSLV | 1591 | Q96N67 | |
| RVKMQVTMSLASLVG | 1546 | Q8NF50 | |
| TKTRSMMALLVQLLS | 691 | Q9UBT7 | |
| STMKILTLNSNMVGL | 111 | Q99928 | |
| VDSKTGVIRTALMNM | 216 | Q9HBT6 | |
| KMPQVTVDVLQRMLI | 261 | O15360 | |
| QGQTKEKMVTMVSVL | 391 | Q96JB5 | |
| MTTMGQFVLSIKVTD | 1631 | Q8TDW7 | |
| MLTLAKNMEVRAIFT | 381 | P09543 | |
| LEKTVLVMNTVMSFR | 1206 | Q0VDD8 | |
| QIMTRMTSDLIQEKL | 441 | Q5I0G3 | |
| GTKMEQTKTAMNVIL | 296 | Q6UXX5 | |
| MVVSSNGAIMTTKLV | 486 | Q7Z589 | |
| NSILKVLISMQLMSG | 131 | Q5T8I3 | |
| VVMTAIQELMSKEIL | 151 | Q9UJC3 | |
| VAQMSLIEAKMRFIQ | 546 | Q96AC1 | |
| MVRQEESLMPSQVVK | 396 | Q9H4M9 | |
| ERLISQIKMVTRVMF | 271 | P46059 | |
| SIMKNMATELGIILI | 391 | Q12770 | |
| MLNRVMTKDNIGVAV | 316 | Q9ULM6 | |
| QRTATVVMMTRLEEK | 1441 | P10586 | |
| NSTIIVMLTKLREMG | 1731 | P10586 | |
| NSTIVVMLTKLREMG | 1736 | P23468 | |
| RKMLVEAIMLLTATA | 286 | Q9BTY7 | |
| IMLAIITKMTLTQVS | 161 | P78415 | |
| MEVQKEAQRIMTLSV | 1 | Q9BTL4 | |
| AGLDMRKTLASVIIM | 56 | A6NES4 | |
| RKMISQAQKVIAVVM | 166 | A6ND36 | |
| TVRENKLLLMFGMTT | 251 | Q9NYW0 | |
| MKRVRTEQIQMAVSC | 1 | O75529 | |
| MGETVMSVKIIRNRL | 26 | Q9NX07 | |
| VGIRVSMMLVQKVQD | 196 | Q6YHU6 | |
| GAKTLMNTIMQLRKI | 1001 | P51531 | |
| VMQKLLRKQESTVMV | 451 | Q9UHX1 | |
| LRKQESTVMVLRNMV | 456 | Q9UHX1 | |
| TARMQVLKRQVQSLM | 221 | Q969G3 | |
| QMKMIVTRGESVLQN | 3336 | Q8NF91 | |
| IRTSELRLSMQKSMQ | 506 | P31040 | |
| IKQMMDVSRTQTAIS | 1451 | Q5JRA6 | |
| MNVKGKVILSMLVVS | 1 | Q4G0N0 | |
| IMLAIITKMTLTQVS | 161 | P78414 | |
| VSTGILMSLSNILKM | 806 | Q9NTG1 | |
| KTVLMLADQMISRIE | 111 | P48729 | |
| MTIRLQSLTMTAEQK | 1731 | Q8IVL1 | |
| GTKTLMNTIMQLRKI | 1031 | P51532 | |
| FQSLVSKLRSQVMSM | 466 | Q9H0W8 | |
| MFLQRKGQVIMTIEL | 956 | O75182 | |
| QISLATQMVRMILKI | 516 | P48643 | |
| MMLNIINSSITTKAI | 151 | P49368 | |
| VKAAMFILTRNVLMT | 146 | Q8NH54 | |
| ELKQMVMSLRVSELQ | 6 | O75925 | |
| RRKMQTVSNISITGM | 361 | Q969I6 | |
| ATKRIMVITVSLIML | 296 | Q96K37 | |
| MVSVVELKQSSVMQR | 251 | Q12769 | |
| MGVLMSKRQTVEQVQ | 1 | Q9UPV7 | |
| GLVNFSKMRMISHII | 1211 | Q13972 | |
| VGRVLAMLVQEMKSI | 791 | O15047 | |
| AKLTIQMMSPLQIER | 176 | Q8WUJ0 | |
| SLTKGLRTMVEQNLM | 536 | Q86YF9 | |
| LMSEKEARSIIMQIV | 561 | Q86UE8 | |
| MMTHVLSTVNVILGK | 791 | Q8IZF2 | |
| VKMLRLALTVTSMTF | 21 | Q9UBR5 | |
| MLNRVMTKDNIGVAV | 316 | Q96LI5 | |
| DQLMVLKQLGISATM | 146 | P46063 | |
| TTDNMLKILAIEMRF | 2396 | Q63HN8 | |
| FLSAIVMMKNRRSIT | 71 | Q9Y320 | |
| TDMLQTIRQFMTQVK | 551 | Q8WYP3 | |
| MMSIKAFTLVSAVER | 1 | Q8WUH2 | |
| NTVATVMALRREKMF | 501 | P49588 | |
| MAKMIIRLVTAIGDV | 616 | P11217 | |
| VMTVKDLNTATRMTA | 156 | Q9UBI4 | |
| AKLSMINTMSKIRGQ | 66 | Q99962 | |
| MKRTALVANTSNMPV | 306 | P38606 | |
| TQQTMEEALGRVKLM | 346 | O00534 | |
| MRIQDTLDLVMKTLS | 401 | Q96LQ0 | |
| MLMLITSIAFKVQRS | 46 | Q9UFV1 | |
| AVLVSALVLMAMVKR | 296 | P0DTU4 | |
| EITAVLEMKSRLQMR | 1256 | Q8N9V7 | |
| EQLISRAVKNMVGML | 1846 | Q96AY4 | |
| SQATMEIIIGMRTQL | 926 | Q9H6S0 | |
| TAMLMAASVARKAVV | 411 | Q8N1G0 | |
| VARILGVTKEMQTLM | 601 | Q8N5H7 | |
| GMVMIFTLVTAVQEK | 96 | Q9H446 | |
| VKLEMNTLNVMLGTL | 4526 | Q5T4S7 | |
| RKMALIQMGSVEEAV | 491 | P26599 | |
| IDRLISVFMRSLQKM | 2286 | Q9Y4A5 | |
| VELGSMQVMNKTRRI | 56 | Q8IWU5 | |
| MQQDVTVGRSLLMTI | 161 | P51811 | |
| SMKLMAVVASTVLGL | 561 | Q8NHX9 | |
| VLVTMVMRLTNTNGE | 436 | Q9NQA5 | |
| TVMGLITRMFKQTAI | 306 | Q5FWF4 | |
| LGVLTMSQLMKRQLE | 1916 | Q9P2D8 | |
| SGIMTMLNMQFVVRV | 336 | Q02108 | |
| LNGVMVAVAELLSMK | 4796 | O14686 | |
| RDMKVLKMSQSIIVS | 136 | Q9UM54 | |
| QMEADMIKLRTQITT | 1081 | Q9UL68 | |
| MIKLRTQITTMESNL | 1086 | Q9UL68 | |
| ASVLKMLQAARDMVT | 891 | Q14957 | |
| LQQTKEMDLSVVRLM | 201 | P19838 |